Loading clinical trials...
Loading clinical trials...
Anomalous Motor System Physiology in Attention Deficit Hyperactivity Disorder: Biomarker Validation and Modeling Domains of Function
Conditions
Interventions
Methylphenidate
Placebo
Locations
2
United States
Kennedy Krieger Institute
Baltimore, Maryland, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
September 1, 2020
Primary Completion Date
February 1, 2026
Completion Date
April 1, 2026
Last Updated
June 19, 2025
NCT05631626
NCT04378517
Lead Sponsor
Donald Gilbert, MD, MS, FAAN, FAAP
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions